Facebook
Twitter
Telegram
Report an ErrorSpringWorks Therapeutics Financial Statements 2011-2024 | SWTX
Annual Financial Statements SpringWorks Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
3.26 B | 1.7 B | 2.74 B | 3.73 B | 448 M | - | - | - | - | - | - | - | - |
Shares |
63.1 M | 53.3 M | 48.5 M | 43.3 M | 13.3 M | - | - | - | - | - | - | - | - |
Historical Prices |
51.6 | 32 | 56.6 | 86 | 32 | - | - | - | - | - | - | - | - |
Net Income |
-325 M | -277 M | -174 M | -45.6 M | -58.3 M | -17.8 M | - | - | - | - | - | - | - |
Revenue |
5.45 M | - | -988 K | 35 M | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
422 K | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-343 M | -281 M | -173 M | -46.3 M | -59.2 M | -18.5 M | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | 25 K | - | 678 K | - | - | - | - | - | - | - |
EBITDA |
-341 M | -280 M | -173 M | -46 M | -59 M | -18.5 M | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | 81.3 M | 59.2 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
198 M | 135 M | 71.8 M | 29.5 M | 16.7 M | 8.59 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement SpringWorks Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
73.8 M | 73.5 M | 62.5 M | 62.5 M | 62.3 M | 62.4 M | 52.9 M | 49.1 M | 48.9 M | 49.2 M | 48.6 M | 48.4 M | 48.2 M | 48.8 M | 42.1 M | 41.9 M | 41.8 M | 43 M | 9.49 M | 879 K | 680 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-87.4 M | - | -79.4 M | -77.9 M | -73.4 M | - | -72.4 M | -69 M | -61.8 M | - | -41 M | -47 M | -29.8 M | - | -21.7 M | -19.9 M | -15.3 M | -16.2 M | -16.8 M | -13.8 M | -11.4 M | -6.22 M | -5 M | -4.02 M | -2.57 M | -4.64 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
21 M | - | - | - | - | - | -1.49 M | - | -337 K | - | -267 K | -159 K | -261 K | - | -130 K | -229 K | -100 K | - | -2.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
1.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-93.9 M | - | -84 M | -82.9 M | -77.7 M | - | -71.7 M | -69 M | -61.5 M | - | -40.9 M | -47 M | -29.8 M | - | -21.6 M | -19.8 M | -16.1 M | -17.4 M | -15.3 M | -14.9 M | -11.7 M | -6.45 M | -5.23 M | -4.22 M | -2.59 M | -4.66 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | -76 K | -98 K | -199 K | - | -74 K | -24 K | -193 K | - | -58 K | -41 K | 3 K | - | - | - | 936 K | - | 997 K | - | 279 K | - | 226 K | - | - | 21 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-93.2 M | - | - | - | -77.4 M | - | -71.2 M | -69 M | -61.4 M | - | -40.6 M | -47 M | -29.6 M | - | -21.4 M | -19.7 M | -16.1 M | -17.4 M | -15.2 M | -14.8 M | -11.7 M | -6.45 M | -5.22 M | -4.22 M | -2.59 M | -4.66 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | 84 M | 82.9 M | 77.7 M | - | 71.7 M | 69 M | 61.5 M | - | 40.9 M | 47 M | 29.8 M | - | 21.6 M | 19.8 M | 16.1 M | - | 15.3 M | 14.9 M | 11.7 M | - | 5.23 M | - | - | 4.66 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
60.1 M | - | 46.5 M | 47 M | 44.2 M | - | 35.7 M | 31 M | 27.4 M | - | 18 M | 14.9 M | 12.4 M | - | 7.67 M | 6.87 M | 6.4 M | - | 4.58 M | 3.65 M | 3.26 M | - | 1.82 M | - | - | 1.86 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency